Work

Aggressive Smoldering Curative Approach Evaluating Novel Therapies (ASCENT): A Phase 2 Trial of Induction, Consolidation and Maintenance in Subjects with High Risk Smoldering Multiple Myeloma (SMM): Initial Analysis of Safety Data

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-142584

Authors: Shaji K. Kumar, Al-Ola Abdallah, Ashraf Z. Badros, Betsy Laplant, Binod Dhakal, Melissa Alsina, Rafat Abonour, Cara A. Rosenbaum, William I Bensinger, Manisha Bhutani, Andrzej Jakubowiak, Erica Kim, Brian G.M. Durie

Institutions: Mayo Clinic, University of Kansas Medical Center, University of Maryland Medical Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Medical College of Wisconsin, Moffitt Cancer Center, Weill Cornell Medicine, Weill Cornell Medical Center, Levine Cancer Institute, University of Chicago, Cedars-Sinai Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3095632440

FWCI: 1.906

Cites:

Cited by: 19

Related to: 10